Name: Amati Insights 4 March 2025 - Industrial Bioengineering: still a $4 trillion opportunity?
Start: 2025-04-15T13:35:00Z
End: 2025-04-15T13:35:14.000Z
Location: BrightTALK

Join Dr Paul Jourdan and Gregor Paterson from the WS UK Listed Smaller Companies fund for a portfolio update where they  highlight current challenges on the UK small-cap market,  and why valuations today present compelling long-term opportunities.



•    UK small-cap valuations are at historic lows - offering attractive entry points for investors.

•    Recovery expected in 2026 - supported by falling interest rates and cyclical sectors like housing and consumer stocks.

•    Portfolio highlights include - Trainline, Gamma Communications, Ashtead Technologies, and Boku—companies with strong fundamentals and growth potential.

⚠️Warning: Capital at Risk. Professional Investors Only

WS Amati UK Listed Smaller Companies Fund - Portfolio Update 11 December 2025

In our latest Amati Insights discussion, Dr Paul Jourdan and Gregor Paterson from the WS Amati UK Listed Smaller Companies Fund share their thoughts on the recent UK budget — from its drawn-out lead-up and unexpected spending increases to its impact on inflation, bond markets, and interest rates. With rate cuts likely ahead, could this be the catalyst for renewed confidence in UK equities?

⚠️Warning: Capital at Risk. Professional Investors Only

Post Budget Review - Amati Insights 2 December 2025

Join Mikhail Zverev and Graeme Bencke from the WS Amati Global Innovation team for a portfolio update. Discover how their disciplined, research-driven approach has enabled them to uncover innovation opportunities beyond the ubiquitous mega-cap tech stocks.

In this short update, Mikhail and Graeme will:

•    Explain the principles behind our investment process and why we focus on real businesses, not science projects;

•    Key innovation frontiers in the portfolio that we believe remain significantly underappreciated by the market;

•    Highlight how today’s shifting geopolitical and trade landscape opens new doors for active investors.

⚠️ Warning: Capital at Risk. Professional Investors Only

#AmatiGlobal #Global #Innovation #Investing #fundresearch #AI #bioprocessing #RFID #fundmanager

WS Amati Global Innovation Fund - Portfolio Update 27 November 2025

Recent conversations with the industry suggest that RFID and other wireless IoT technologies continue to unlock new transformative applications – from retail to healthcare to everyday consumer life. 



Join Amati Global Innovation fund managers Mikhail Zverev and Graeme Bencke as they discuss how they are investing to benefit from what’s coming next.

Amati Insights: RFID 2.0 – accelerating adoption

Alzheimer's Disease is one of the most pressing unmet clinical needs and is a huge cost to healthcare systems and societies.

Recent developments in Alzheimer's diagnostics are nothing short of revolutionary and promise to unlock improved patient outcomes and valuable new markets.

Join Mikhail Zverev and Graeme Bencke as they discuss how they pursue this opportunity in the WS Amati Global Innovation Fund. 

⚠️ Warning: Capital at Risk. Professional Investors Only.

Alzheimer’s Disease: diagnostics revolution - Amati Insights 4 November 2025

Photonics and optical communications have been key enablers of the digital revolution. With AI, the industry is entering a hyper-growth stage. 

Join Amati managers Mikhail Zverev and Graeme Bencke to hear why the transition to optical data communication is inevitable and where they see investment opportunities benefiting from this technological change.

Photonics and Optical Communications in the Age of AI - Amati Insights 21 October 2025

The nature of warfare is changing and innovations in electronic warfare, advanced communications and drone and missile defence are developing at pace. Join Gregor Paterson from the Amati UK Small Cap Fund and Graeme Bencke from the Amati Global Innovation Fund as they discuss these trends and the associated investment implications.

Defence Update - Amati Insights 7 October 2025

With the recent rally in commodity prices, have you missed the boat? Georges Lequime and Mark Smith provide an overview of where commodity prices, in particular gold and silver have gone, where they could end up and what the market’s present pricing suggests. They will also cover the shape of the portfolio, asset split and equity weightings.

Amati Strategic Metals Fund - Commodity Price Rally: Have you missed the boat?

Amati Insights restarts after the break with a look back at Innovation progress and breakthroughs during the summer, which was anything but quiet. The market is singularly focused on generative AI and the data centre boom, but there is a lot more going on: forward leaps in detecting Alzhemier's and rare genetic diseases, changing priorities in global defence, more sustainable battery tech, and even the ability to bring professional inventory tracking to your home or your phone. Mikhail Zverev, Graeme Bencke and Gareth Blades from the Amati Global Innovation team will highlight some exciting technological changes and new opportunities for investors - outside of the AI spotlight.

Innovation beyond AI - Amati Insights 23 September 2025

What was supposed to be a quiet summer has turned out anything but. Usually, over the summer months, precious metal prices weaken with the stronger months typically being end of August through the whole of September, when everyone is back from holidays. However, the last six weeks have been eventful and positive for the mining sector.

Georges Lequime, co-manager of the WS Amati Strategic Metals Fund, offers insight into recent developments within the sector in this short vlog. 

⚠️ Warning: Capital at Risk. Professional Investors Only.

Amati Strategic Metals Fund Vlog - Recent Developments within the Sector

Scott Mckenzie & Dr Paul Jourdan will offer an update on the Amati AIM IHT portfolio service and highlight fund performance, portfolio activity and outlook for the sector

Outlook & Opportunities for AIM

Medical Diagnostics is an exciting growth area. Demand for diagnostics from patients and health professionals is combined with and amplified by the innovation and biological discovery in biomarkers and testing techniques. Gareth Blades and Mikhail Zverev from Amati Global Innovation team discuss the new opportunities this unlocks for investors in the latest Amati Insights.

Amati Insights 24 June 2025 - Medical Diagnostics

Amati Fund Managers will explain the process of conducting a site visit for investment due diligence - by highlighting the site visit to Reunion Gold and G2 Goldfields in Guyana, South America. These 2 investments have returned over 200% investment for the WS Amati Strategic Metals Fund since the site visit.  # 'You can't lick rocks and kick the tyres from a Bloomberg Screen!'

Geology 101:  boots on the ground

Join the Amati Global Innovation team for a Brighttalk session as the fund celebrates its 3 year anniversary.   The team will explain the principles of their investment approach which has enabled them to discover innovation opportunities beyond the ubiquitous mega-cap tech stocks. The brief presentation will include insights into the highest conviction innovation themes in the portfolio, which the team believes are significantly under-appreciated by the market consensus, as well as discussing the current volatile geopolitical and trade environment and the opportunities this presents for long-term investors.

Finding technological inevitability in an uncertain world

Dr Paul Jourdan and Gregor Paterson from the Amati UK smallcap team discuss the sentiment towards UK markets, the recent indication from Mansion House Compact that pension funds will be allocating to private markets including AIM, what sectors will be leading the way in the small cap space and what the key themes are likely to be for the second half of 2025.

Amati Insights 9 June 2025 - AIM at 30 years old: is the UK small cap market at a turning point?

Investors in UK smaller companies have endured a perfect storm in recent years, with returns depressed by persistent fund outflows and the significant underperformance of the AIM index. This presents us with some outstanding investment opportunities across a range of high quality UK companies. With global investors recently questioning the dominance of US equities in their portfolios and UK capital market reforms now increasingly likely , we provide an update on why we believe that the WS UK Listed Smaller Companies Fund is ideally placed to capture the upside.

"UK Smallcap - Buy While Stocks Last "

NVidia and the Magnificent 7 take all the headlines in the AI race but humble "commodity" memory chips also stand to benefit. In the wake of Computex show in Taiwan Amati managers Mikhail Zverev and Graeme Bencke revisit why memory is a big beneficiary of AI growth, and what the opportunities are for investors.

Amati Insights 27 May 2025 - Memory Chips: The Coming AI Demand Super-Cycle

Investment in electric grids was already in growth mode. Spanish blackouts, German infrastructure stimulus and Trump administration deregulation agenda are poised to accelerate it. Join Amati managers Graeme Bencke and Mikhail Zverev to discuss the investment implications of this change

Amati Insights 13 May 2025 - "Trump, Merz and Spanish Blackouts: Powering up the Growth in Electric Grid Modernisation."

Although this remains years away, the direction of travel across industries is clear. Mikhail Zverev and Graeme Bencke discuss the roadmap towards the living factory and the investment implications in the latest Amati Insights.

Amati Insights 29 April 2025 - Autonomous Factory - the future of industrial manufacturing?

Recent breakthroughs in radiation therapies are the crest of the wave for a new frontier of cancer diagnostics and treatments. Join Graeme Bencke and Dr Gareth Blades of the Amati Global Innovation Fund as they discuss the innovations taking place and the potential opportunities for informed investors.

Amati Insights 21 January 2025 - Precision medicine:  a nuclear option?

Release of the DeepSeek AI model has caused some extreme market reactions and a lot of soul searching in the investment industry. As the dust settles and more information comes to light, Amati managers Mikhail Zverev and Graeme Bencke discuss the implications and consider how pragmatic and disciplined innovation investors should navigate this development.

Amati Insights 4 February 2025 - DeepSeek: popping the AI bubble or accelerating the AI growth?

The Trump generated headlines just keep coming. David Stevenson and Gregor Paterson discuss the impact of recent US policy initiatives on the outlook for some key global sectors.

Amati Insights 15 February 2025 - Global Industrials & Defence

The life sciences industry is an important driver of innovation but facing challenges and opportunities under the new US administration.  Join Dr Gareth Blades for an investor update on the sector following his recent visit to the US

Amati Insights 18 March 2025 - Life Sciences under Trump: threats and opportunities

As labour costs continue to rise so does the interest in robotics and automation, both important frontiers for the Amati Global Innovation Fund. Following a recent visit to the UK’s largest automation trade show, join Mikhail Zverev and Graeme Bencke as they discuss the latest insights and investment implications.

Amati Insights 1 April 2025 - The robots are coming ... and revolutionising logistics

Following President Trump’s commitment to impose tariffs worldwide, join Amati Insights  with fund managers Dr Paul Jourdan, Georges Lequime & Graeme Bencke who will offer their thoughts and perspectives on the recent market gyrations.

Amati Insights 15 April 2025 - Trump Tariff Terror

The geopolitics of the unexpected gold price boom.

A conversation between Paul Jourdan, CEO of Amati Global Investors and Kieron Hodgson, Managing Director, Commodities & Mining Research at Panmure Gordon.

Amati Insights - 23rd April 2024

Recent geopolitical tensions and the disruptions through the pandemic have highlighted the risks of relying on globalised supply chains. The result is a wave of ‘reshoring’ and ‘near-shoring’ of production to avoid these problems in the future. Join David Stevenson and Graeme Bencke in the latest Amati Insights call as they discuss investing in the potential beneficiaries of this process.

9th April 2024 - Risks of Relying on Globalised Supply Chains

In March, the US FDA approved a next generation surgical robot, the 5th generation Da Vinci robot, developed by Intuitive Surgical. This showcases rapid progress in “robotic assisted surgery”, an exciting Innovation Frontier that is transforming surgery field.

Join Dr Gareth Blades and Mikhail Zverev as they discuss why this is important, who the leading players are in this sector and what opportunities this presents for global and UK equity investors.

26th March 2024 - Robotic Surgery

Big tech may get all the headlines, but innovation in healthcare is also progressing at a rapid pace. This week, Gareth and Mikhail from the Amati Global Innovation team discuss recent findings from a leading global healthcare conference.

12th March 2024 - Innovation in healthcare

“Magnificent 7," largest US technology stocks, continue to dominate US and Global markets performance. Graeme Bencke and Mikhail Zverev will look at the underlying drivers, valuations and fundamentals behind this group of companies and discuss the world of innovation opportunities that lie beyond.

27th February 2024 - Magnificent 7

After several years of outflows we are now seeing early signs of recovery in the UK smaller companies sector. Scott McKenzie and David Stevenson examine why increasing share buybacks and healthy dividend yields are helping to underpin the compelling valuations now on offer across the asset class.

13th February 2024 - UK Smallcap Buybacks & Dividends

The nature of warfare is changing and emerging new threats demand innovative technological solutions from the armed forces and the defence industry. Join David Stevenson and Graeme Bencke for an overview of what this means for the Aerospace and Defence sector and the opportunities this brings to UK and Global equity investors.

30th January 2024 – Innovation and the changing nature of warfare

Join Dr Gareth Blades & Graeme Bencke as they discuss the outlook for the new, much publicised ‘GLP-1’ weight-loss drugs. What are they, how the competing products differ, and what are the implications for other weight and diabetes management approaches and the broader healthcare system.

16th January 2024 – GLP-1 weight-loss drugs

Before we break for Christmas and New Year, Paul Jourdan and Mikhail Zverev look back on 2023, share their observations on UK and global equity markets and talk about what they have changed in their positioning and the outlook for investors in 2024.

12th December 2023 – 2023 in the UK and Global markets – a year to forget?

Radio Frequency Identification technology is starting to change our everyday life. It enables automated self-check-outs at retailers Uniqlo and Zara and will power parcel tracking at UPS. In more specialist applications it will drive safer pharmaceuticals supply chain, auto parts quality control and EV battery recycling. Amati managers Graeme Bencke and Mikhail Zverev discuss why RFID matters and what opportunities do they see to benefit from this technological change.

28th November 2023 – Radio Frequency Identification Technology

Semiconductors are one of the most dynamic sectors in the global market, and UK small caps also present interesting opportunities to benefit from semiconductor industry growth. Amati managers David Stevenson and Mikhail Zverev discuss key themes driving the industry and where they see opportunities in both global and UK stocks.

14th November 2023 – Investing in Semiconductor Industry

The photonics industry are unsung heroes of the digital revolution. The technology that brought us fast home broadband is also accelerating AI in the data centres, connecting 5G networks and may even replace copper wires between server chips. Amati managers Graeme Bencke and Mikhail Zverev discuss long-term opportunities and near-term challenges that the industry is facing and their picks for the Amati Strategic Innovation fund.

31st October 2023 – Opportunities in Photonics Industry

We have all seen headlines and political debate on diluting net zero commitments, from low emission zones to EVs to renewable energy. Beyond politics, there are objective economic headwinds – cost inflation and higher interest rates made previously feasible projects untenable. We have seen project cancellations and guidance downgrades across renewable energy space. Amati fund managers Mikhail Zverev and Graeme Bencke will consider the implications and talk about how they’re navigating this complex environment in the Amati Strategic Innovation Fund.

3rd October 2023 – Diluting Net Zero Commitments

The obscure but exciting world of bioprocessing. You may have seen press headlines about break-through obesity treatments, promising progress in Alzheimer therapy or cure for previously incurable cancers. Gareth and Mikhail discuss how the bioprocessing industry has become a key enabler of this innovation, why now is a good time to look for opportunities on the sector and what choices they have made for our funds.

19th September 2023 – Bioprocessing

Paul Jourdan and Mikhail Zverev will share their summer reflections on themes in global markets and the Edinburgh Festivals, from Generative AI boom to China economic stumble, from re-industrialisation of the West to oil & gas industry boycotts.

5th September 2023 – Where do we go from here?

Before we enter the (hopefully) quieter summer months, fund managers, Graeme Bencke and Mikhail Zverev will discuss some of the big open questions in front of the team that will be the focus of our investment thinking this summer.

27th June 2023 – Our Summer Research To-Do List

Commercial real estate has been in focus in recent months, with worrying headlines regarding falling occupancy, drop in valuation and risk of debt defaults. Amati fund managers Scott McKenzie and David Stevenson will discuss both the UK and Global perspective on this issue and highlight areas where they still see opportunities to generate return in the sector.

13th June 2023 – Commercial Real Estate

Innovation in the life sciences is happening at an ever increasing pace. New tools and technology are revealing richer detail and more insights about health and disease than ever before. These insights translate into vast addressable markets. While still in its early stages, it will continue to have a large impact on clinical applications and patients. Join Dr Gareth Blades and Graeme Bencke who will discuss this changing landscape.

30th May 2023 – Innovation in Life Sciences

Although most stock markets are in positive territory so far this year, the benign headline numbers mask some intriguing dynamics within. Join Amati fund managers Scott McKenzie and Graeme Bencke for the next Insights call as they discuss the underlying trends across both Global and UK markets, and some of the interesting investment opportunities they see.

16th May 2023 – Trends and opportunities across Global & UK Markets

Tesla results and the threat of electric vehicle price war. Tesla has been reducing the price of its electric vehicles in the recent months. In its results announcement, CEO Elon Musk suggested more price cuts are possible, causing the stock to fall 10% on the day. There is talk in the industry of EV price war, on the backdrop of softening macro environment. Amati fund managers Mikhail Zverev and Graeme Bencke will discuss the environment in the EV market and implications for carmakers and the supply chain.

2nd May 2023 – Electric Vehicle Market

ChatGPT has gained rapid popularity and wide publicity since launch. In our opinion, it represents a new chapter in AI and machine learning technology, with far reaching implications. Amati fund managers Mikhail Zverev and Graeme Bencke will discuss the progress so far and consider investment opportunities and risks arising from this technological change.

18th April 2023 - ChatGPT

The next few years will bring a sharp increase in the number and variety of autonomous machines in use across industry and commerce. From inspection drones to warehouse robots and from autonomous cleaners to self-guided tractors. Unmanned mobile machines are quickly becoming part of normal life and this is being made possible by the development of increasingly cheaper and more technically sophisticated sensors. Join David Stevenson and Graeme Bencke to discuss the developments in machine vision and some of the opportunities being uncovered in both our UK and Global funds.

4th April 2023 - Machine Vision

Dr Paul Jourdan and Mikhail Zverev will discuss the failure of Silicon Valley Bank in the US last week, regulatory response and the emerging contagion risks. Managers will consider possible implications for the bank depositors, banking sector stability and regulation and Amati portfolios and positioning.

21st March 2023 - Silicon Valley Bank

Lithium prices have soared almost 10 fold over the past two years as the growth lithium-ion battery production outpaced the available supply of the crucial raw material. With new supply coming on stream, both from existing mine expansions and from the first of a wave of new developments like Sigma Lithium in Brazil, and with Chinese EV demand having been weaker than expected in early 2023, the price is now easing. With EVs forming a significant plank of the initial global drive to lower carbon emissions, the rate at which demand rises will be linked to the success of EV roll out and all the implications this has for expanding power generation and grid capacity. New supply of lithium is highly dependent on the delivery of some large mining projects on time, something which is rare in the world of mining. In the mix, Western Governments want reduced dependence on China. This is a microcosm of many investment conundrums which arise from the challenge of energy transition. Graeme Bencke and Paul Jourdan discussed how this might play out over the new few years.

7th March 2023 - Lithium

The energy market disruption caused by the invasion of Ukraine has caused many countries to rethink their energy strategy. The drive towards net zero provides an obvious preference for low carbon generation, but the need for consistent baseload power means that renewables cannot be the only answer. This need, combined with advancing technology is driving a return to nuclear energy. Georges Lequime and Graeme Bencke will discuss the changes taking place and the outlook for the key associated commodity, Uranium.

21st February 2023 - Nuclear Energy

US Department of Justice last week filed a lawsuit against Alphabet/Google, seeking to break up its advertising business. This continues the seismic shift in the digital advertising industry, driven by both regulatory pressures and technological changes. Two leading digital advertising platforms - Alphabet and Meta, bellwether "big tech" stocks - had also just reported eventful sets of results. Anna Macdonald and Mikhail Zverev discussed how this impacts digital advertising landscape, what are the risks, and where do we find mis-priced growth and innovation opportunities, in both our Global and UK funds.

7th February 2023 - Digital Advertising

Discussion on defence spending, following recent record high US defence spending bill and spending increases by other developed nations. We will look at how technological change and innovation is changing the defence industry, touching on areas such as drone warfare, advanced sensors and computing.

24th January 2023 - Defence Spending

Amati Insights

Using industrial biological processes to manufacture more – food, medicine, energy commodities, agricultural inputs – was once seen as a 4 trillion dollar opportunity. 

After many disappointments, the sector is out of the limelight, but the underlying opportunity may still be intact. Join Amati managers Mikhail Zverev and Graeme Bencke as they explore what’s working today, where the growth is coming from, and what are the biggest long term prizes for this evolving industry.

Amati Insights 4 March 2025 - Industrial Bioengineering:  still a $4 trillion opportunity?

Innovation

Global Equities

industry

bioengineering

Investment Management

investing

Economics

Global Markets

active management

Industrial Manufacturing

This community is for investors who work within the European market providing client and portfolio management advice. Join to learn from trusted investors on the latest trends and account strategies for delivering consistent results and long term success.

European Investors

The accounting and finance community on BrightTALK features presentations from leading accountants and finance professionals. The accounting community includes tax planning strategies, QuickBooks webinars and other accounting webinars, while the finance community features presentations on financial capital regulations and forensic data analytics. Join the conversation by attending live financial and accounting presentations and connecting with industry thought leaders.

Amati Insights 4 March 2025 - Industrial Bioengineering: still a $4 trillion opportunity?

Presented by

About this talk

Amati Global Investors